Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
Wall Street
Price Targets
Price Targets Summary
Tonghua Dongbao Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Tonghua Dongbao Pharmaceutical Co Ltd is 14.37 CNY with a low forecast of 11.53 CNY and a high forecast of 16.52 CNY.
Price Targets
Revenue
Forecast
Revenue Estimate
Tonghua Dongbao Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Tonghua Dongbao Pharmaceutical Co Ltd's revenue is 8%. The projected CAGR for the next 3 years is 12%.
Operating Income
Forecast
Operating Income Estimate
Tonghua Dongbao Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Tonghua Dongbao Pharmaceutical Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 13%.
Net Income
Forecast
Net Income Estimate
Tonghua Dongbao Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Tonghua Dongbao Pharmaceutical Co Ltd's net income is 11%. The projected CAGR for the next 3 years is 11%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Tonghua Dongbao Pharmaceutical Co Ltd's stock price target?
Price Target
14.37
CNY
According to Wall Street analysts, the average 1-year price target for Tonghua Dongbao Pharmaceutical Co Ltd is 14.37 CNY with a low forecast of 11.53 CNY and a high forecast of 16.52 CNY.
What is Tonghua Dongbao Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
12%
For the last 8 years the compound annual growth rate for Tonghua Dongbao Pharmaceutical Co Ltd's revenue is 8%. The projected CAGR for the next 3 years is 12%.
What is Tonghua Dongbao Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
13%
For the last 8 years the compound annual growth rate for Tonghua Dongbao Pharmaceutical Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 13%.
What is Tonghua Dongbao Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
11%
For the last 8 years the compound annual growth rate for Tonghua Dongbao Pharmaceutical Co Ltd's net income is 11%. The projected CAGR for the next 3 years is 11%.